Horiguchi M, Fujioka M, Kondo T, Fujioka Y, Li X, Horiuchi K, O Satoh A, Nepal P, Nishide S, Nanbo A, Teshima T, Ohba Y.:Improved FRET biosensor for the measurement of BCR-ABL activity in chronic myeloid leukemia cells.:Cell Struct Funct. 2016 Dec 8. Epub
英文原著
Chen YB, Wang T, Hemmer MT, Brady C, Couriel DR, Alousi A, Pidala J, Urbano-Ispizua A, Choi SW, Nishihori T, Teshima T, Inamoto Y, Wirk B, Marks DI, Abdel-Azim H, Lehmann L, Yu L, Bitan M, Cairo MS, Qayed M, Salit R, Gale RP, Martino R, Jaglowski S, Bajel A, Savani B, Frangoul H, Lewis ID, Storek J, Askar M, Kharfan-Dabaja MA, Aljurf M, Ringden O, Reshef R, Olsson RF, Hashmi S, Seo S, Spitzer TR, MacMillan ML, Lazaryan A, Spellman SR, Arora M, Cutler CS.:GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes.:Bone Marrow Transplant. 2016 Dec 12. Epub
Kanaya M, Shibuya K, Hirochika R, Kanemoto M, Ohashi K, Okada M, Wagatsuma Y, Cho Y, Kojima H, Teshima T, Imamura M, Sakamaki H, Shibuya A.:Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease.:PLoS One. 2016 Jun 3;11(6):e0154173.
Terakura S, Wake A, Inamoto Y, Murata M, Sakai R, Yamaguchi T, Takahashi S, Uchida N, Onishi Y, Ohashi K, Ozawa Y, Kanamori H, Yamaguchi H, Fukuda T, Ichinohe T, Takanashi M, Atsuta Y, Teshima T.:Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.:Bone Marrow Transplant. 2016 Dec 12. Epub
Mori Y, Ikeda K, Inomata T, Yoshimoto G, Fujii N, Ago H, Teshima T.:Ruxolitinib treatment for GvHD in patients with myelofibrosis.:Bone Marrow Transplant. 2016 Dec;51(12):1584-1587.
Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, Ikeda T, Nishida T, Inoue M, Eto T, Kubo K, Sakura T, Mori T, Uchida N, Ashida T, Matsuhashi Y, Miyazaki Y, Ichinohe T, Atsuta Y, Teshima T.:Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT.:Bone Marrow Transplant. 2016 Nov 21. Epub
Sugita J, Miyamoto T, Kawashima N, Hatsumi N, Anzai N, Kaneko H, Nara M, Minauchi K, Harada M, Teshima T.:Prior history of HLA-mismatched stem cell transplantation is a risk factor for graft failure in HLA-haploidentical transplantation.:Bone Marrow Transplant. 2016 Nov 7 Epub
Yang Y, Kelly P, Shaffer AL 3rd, Schmitz R, Yoo HM, Liu X, Huang da W, Webster D, Young RM, Nakagawa M, Ceribelli M, Wright GW, Yang Y, Zhao H, Yu X, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza L, Staudt LM.:Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.:Cancer Cell. 2016 Apr 11;29(4):494-507.
Ibata M, Iwasaki J, Fujioka Y, Nakagawa K, Darmanin S, Onozawa M, Hashimoto D, Ohba Y, Hatakeyama S, Teshima T, Kondo T.:A leukemogenic kinase, FIP1L1-PDGFRA, and a SUMO E3 ligase, PIAS1, form a positive crosstalk via their enzymatic activities.:Cancer Sci. 2016 Dec 13. Epub
Iyama S, Sato T, Ohnishi H, Kanisawa Y, Ohta S, Kondo T, Mori A, Tsutsumi Y, Kuroda H, Kakinoki Y, Yamamoto S, Takahashi T, Shindo M, Torimoto Y, Sato K, Iwasaki H, Haseyama Y, Kohda K, Nagamachi Y, Hirayama Y, Sakai H, Hirata Y, Fukuhara T, Ikeda H, Kobune M, Kato J, Kurosawa M.:A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma.:Clin Lymphoma Myeloma Leuk. 2016 Sep 17. pii: S2152-2650(16)30565-1.
Inamoto Y, Kimura F, Kanda J, Sugita J, Ikegame K, Nakasone H, Nannya Y, Uchida N, Fukuda T, Yoshioka K, Ozawa Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, Inoue M, Teshima T; JSHCT GVHD Working Group..:Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.:Haematologica. 2016 Dec;101(12):1592-1602.
Arai Y, Kondo T, Yamazaki H, Takenaka K, Sugita J, Kobayashi T, Ozawa Y, Uchida N, Iwato K, Kobayashi N, Takahashi Y, Ishiyama K, Fukuda T, Ichinohe T, Atsuta Y, Mori T, Teshima T; Japan Society for Hematopoietic Cell Transplantation..:Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.:Haematologica. 2016 May;101(5):644-52.
Shiratori S, Fujimoto K, Nishimura M, Hatanaka KC, Kosugi-Kanaya M, Okada K, Sugita J, Shigematsu A, Hashimoto D, Endo T, Kondo T, Abe R, Hashino S, Matsuno Y, Shimizu H, Teshima T.:Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.:Hematol Oncol. 2016 Mar;34(1):9-16.
Todo S, Yamashita K, Goto R, Zaitsu M, Nagatsu A, Oura T, Watanabe M, Aoyagi T, Suzuki T, Shimamura T, Kamiyama T, Sato N, Sugita J, Hatanaka K, Bashuda H, Habu S, Demetris AJ, Okumura K.:A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.:Hepatology. 2016 Aug;64(2):632-43.
Salmon H, Idoyaga J, Rahman A, Leboeuf M, Remark R, Jordan S, Casanova-Acebes M, Khudoynazarova M, Agudo J, Tung N, Chakarov S, Rivera C, Hogstad B, Bosenberg M, Hashimoto D, Gnjatic S, Bhardwaj N, Palucka AK, Brown BD, Brody J, Ginhoux F, Merad M. :Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.:Immunity. 2016 Apr 19;44(4):924-38.
Matsukawa T, Hashimoto D, Sugita J, Nakazawa S, Matsushita T, Kashiwazaki H, Goto H, Onozawa M, Kahata K, Fujimoto K, Endo T, Kondo T, Hashino S, Yamazaki Y, Teshima T.:Reduced-dose methotrexate in combination with tacrolimus was associated with rapid engraftment and recovery from oral mucositis without affecting the incidence of GVHD.:Int J Hematol. 2016 Jul;104(1)
Miyamoto T, Takashima S, Kato K, Takase K, Yoshimoto G, Yoshida S, Henzan H, Osaki K, Kamimura T, Iwasaki H, Eto T, Teshima T, Nagafuji K, Akashi K.:Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation.:Int J Hematol .2016 Sep 29 Epub
Tazawa Y, Shigematsu A, Kasashi K, Sugita J, Endo T, Kondo T, Teshima T, Iseki K, Sugawara M, Takekuma Y.:Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantation.:J Pharm Health Care Sci. 2016 Aug 8;2:18.
Yokoyama S, Iwano H, Yamada S, Takeda M, Kaga S, Nakabachi M, Nishino H, Ichikawa A, Abe A, Okada K, Murai D, Hayashi T, Nishida M, Shibuya H, Kahata K, Shimizu C, Mikami T, Tsutsui H. :Long-term echocardiographic evaluation of valvular lesions in a patient with nonbacterial thrombotic endocarditis associated with advanced uterine cancer. :J. Cardiology of Cases, 2016, 14(3), 82-86
Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M.:Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.:Leukemia. 2016 Nov 4. Epub
Ito S, Tsutsumi Y, Ohigashi H, Shiratori S, Teshima T.:Determination of prognosis of Philadelphia chromosome-negative myeloproliferative neoplasms with a simple clinical examination: Retrospective analysis of 71 patients in a single institution.:Mol Clin Oncol. 2016 Jan;4(1):51-57.
Raja E, Tzavlaki K, Vuilleumier R, Edlund K, Kahata K, Zieba A, Morén A, Watanabe Y, Voytyuk I, Botling J, Söderberg O, Micke P, Pyrowolakis G, Heldin CH, Moustakas A. :The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signaling.:Oncotarget. 2016 Jan 12;7(2):1120-43.
Shimono J, Miyoshi H, Seto M, Teshima T, Ohshima K.:Clinical features of diffuse large B-cell lymphoma with polyploidy.:Pathol Int. 2016 Nov 21. Epub
Hodson DJ, Shaffer AL, Xiao W, Wright GW, Schmitz R, Phelan JD, Yang Y, Webster DE, Rui L, Kohlhammer H, Nakagawa M, Waldmann TA, Staudt LM.:Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2.:Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2039-46.
Miyashita N, Endo T, Onozawa M, Hashimoto D, Kondo T, Fujimoto K, Kahata K, Sugita J, Goto H, Matsukawa T, Hashino S, Teshima T.:Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.:Transpl Infect Dis. 2016 in press
Shiratori S, Tateno T, Ito S, Tsutsumi Y, Teshima T.:Evaluation of Short-Term Ruxolitinib Tapering Strategy Before Allogeneic Stem Cell Transplantation for Primary Myelofibrosis Through the Transition of Serum Cytokines and Growth Factors.:Transplant Direct. 2016 Jul 22;2(8):e95.
Nakano K, Yasuda K, Shibuya H, Moriyama T, Kahata K, Shimizu C.:Transient human anti-mouse antibody generated with immune enhancement in a carbohydrate antigen 19-9 immunoassay after surgical resection of recurrent cancer. :Ann Clin Biochem. 2016 Jul;53(Pt 4):511-5.
Yamaguchi Y, Ujiie H, Ohigashi H, Iwata H, Muramatsu K, Endou T, Teshima T, Shimizu H.:Linear IgA Bullous Dermatosis Associated with Immunoglobulin Light-chain Amyloidosis.:Acta Derm Venereol. 2016 Nov 24. Epub
Aoki J, Kanamori H, Tanaka M, Yamasaki S, Fukuda T, Ogawa H, Iwato K, Ohashi K, Okumura H, Onizuka M, Maesako Y, Teshima T, Kobayashi N, Morishima Y, Hirokawa M, Atsuta Y, Yano S, Takami A.:Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia.:Am J Hematol. 2016 Mar;91(3):302-7.
Kuwatsuka Y, Kanda J, Yamazaki H, Mori T, Miyamura K, Kako S, Uchida N, Ohashi K, Ozawa Y, Takahashi Y, Kato C, Iwato K, Ishiyama K, Kobayashi H, Eto T, Kahata K, Kato J, Miyamoto T, Kato K, Mori S, Atsuta Y, Kimura F, Kanda Y; Japan Society for Hematopoietic Cell Transplantation.:A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia. :Biol Blood Marrow Transplant. 2016 Oct;22(10):1836-43.
Kanaya M, Hayashi Y, Hashimoto D, Endo T, Sugita J, Ohigashi H, Hashiguchi J, Matsukawa T, Matsuoka S, Kosugi-Kanaya M, Goto H, Onozawa M, Kahata K, Fujimoto K, Kondo T, Akizawa K, Shibuya H, Shimizu C, Teshima T.:MALDI-TOF MS in post transplant blood stream infections: reliable identification of causative bacteria in neutropenic phase. :Bone Marrow Transplantation (in press)
Tsutsumi Y, Ito S, Ohigashi H, Shiratori S, Teshima T.:Unplanned discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia.:Mol Clin Oncol. 2016 Jan;4(1):89-92.
英文症例報告
Takashima S, Nishie W, Morita Y, Osawa R, Iwata H, Fujita Y, Fujimoto K, Shimizu H.:Eosinophilic pustular folliculitis in a patient with mycosis fungoides.:J Eur Acad Dermatol Venereol. 2016 Apr;30(4):712-3.
Ohe M, Hashino S. :A cese of idiopathic pulmpnary fibrosis treated with clarithromycin.:East J Med. 2016 Jan-Mar;21(1):39-41
Takahashi S, Tsumanuma R, Aizawa K, Osakabe M, Maeda K, Omoto E.:Early Improvement in Marrow Fibrosis Following Haploidentical Stem Cell Transplantation for a Patient with Myelodysplastic Syndrome with Bone Marrow Fibrosis.:Intern Med. 2016;55(22):3351-3356.
Tsutsumi Y, Ohigashi H, Ito S, Shiratori S, Teshima T.:5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report.:J Med Case Rep. 2016 Feb 2;10:27.
Ohe M, Hashino S.:Successful treatment of angioimmunoblastic T-cell lymphoma with clarithromycin.:Blood Res. 2016 Jun;51(2):139-42.
Kasahara K, Onozawa M, Miyashita N, Yokohata E, Yoshida M, Kanaya M, Kosugi-Kanaya M, Takemura R, Takahashi S, Sugita J, Shigematsu A, Takahata M, Fujisawa S, Hashimoto D, Fujimoto K, Endo T, Kondo T, Teshima T.:Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy.:Case Rep Hematol. 2016;2016:2373902.
Ohe M, Hashino S, Nagai K, Hattori A, Furuya K.:Primary Pulmonary Hodgkin Lymphoma Associated with Primary Sjögren's Syndrome:Ewha Med J. 2016 Jul;39(3):95-98.
Shiba K, Abe R, Miyauchi T, Nomura T, Kondo T, Shimizu H.:Massive petechiae as an initial symptom of Waldenström's macroglobulinemia.:Int J Dermatol. 2016 Jun;55(6):e361-2.
Kuriyama T, Kato K, Sakamoto K, Hayashi M, Takashima S, Mori Y, Takenaka K, Iwasaki H, Teshima T, Harada N, Nagafuji K, Miyamoto T, Akashi K.:Cord Blood Transplantation Following Reduced-intensity Conditioning for Adult-onset Inherited Hemophagocytic Lymphohistiocytosis.:Intern Med. 2016;55(6):667-71.
Tsutsumi Y, Tateno T, Ito S, Shiratori S, Teshima T.:Successful T-cell Replete Hematopoietic Stem Cell Boost Without Conditioning for Late Graft Failure.:Transplant Proc. 2016 Nov;48(9):3225-3226.
和文総説
藤本勝也、杉田純一、豊嶋崇徳:HLA半合致移植の現状と展望. :臨床血液 57(3):288-97. 2016 Mar.
